menu toggle

We believe in the promise of biosimilars to deliver cost savings across healthcare and we have access to every approved biosimilars launched in the United States. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.

To date, there have been 48 approvals and 38 launches* in the U.S. biosimilar market. Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. With increased biosimilar adoption, we can improve medication access and affordability, and better support the patients we serve.

Below you will find the biosimilars available through Cencora.

 

Biosimilar Reference product Patient support services Drug information
Mvasi (bevacizumab-awwb) Avastin® Amgen Assist 360TM Read more
Zirabev (bevacizumab-bvzr) Avastin® Pfizer Oncology TogetherTM Read more
Alymsys (bevacizumab-maly) Avastin® Amneal PATHways® Read more
Vegzelma (bevacizumab-adcd) Avastin® Vegzelma patient support Read more
Retacrit (epoetin alfa-epbx) Epogen/Procrit® Pfizer enCompass® Read more
Kanjinti (trastuzumab-anns) Herceptin® Amgen Assist 360TM Read more
Ogiviri (trastuzumab-dkst) Herceptin® Viatris Advocate® Read more
Ontruzant (trastuzumab-dttb) Herceptin® Organon Access Program Read more
Trazimera (trastuzumab-qyyp) Herceptin® Pfizer Oncology TogetherTM Read more
Herzuma (trastuzumab-pkrb) Herceptin® Teva Shared Solutions® Read more
Amjevita (adalimumab-atto) Humira® AMJEVITA SupportPlus Co-Pay program Read more
Cyltezo (adalimumab-adbm) Humira® BI Cares Patient Assistance Program Read more
Hadlima (adalimumab-bwwd) Humira® Hadlima patient support Read more
Hulio (adalimumab-fkjp) Humira® Hulio360  Read more
Hyrimoz (adalimumab-adaz) Humira® Sandoz One Source Read more
Idacio (adalimumab-aacf) Humira® Kabicare Read more
Yuflyma (adalimumab-aaty) Humira® Celltrion Connect Read more
Yusimry (adalimumab-aqvh) Humira® Patient Support Services Read more
Abrilada (adalimumab-afzb) Humira® Pfizer enCompass® Read more
Rezvoglar (insulin glargine-aglr) Lantus® Rezvoglar support information Read more
Semglee (insulin glargine-yfgn) Lantus® Semglee Savings and Support Read more
Byooviz (ranibizumab-nuna) Lucentis® Biogen Biosimilar Support Services Read more
Cimerli (ranibizumab-eqrn) Lucentis® Cimerli SolutionsTM Read more
Fulphila (pegfilgrastim-jmdb) Neulasta® Viatris Advocate® Read more
Fylnetra (pegfilgrastim-pbbk) Neulasta® Amneal PATHways® Patient Support Program Read more
Udenyca (pegfilgrastim-cbqv) Neulasta® Coherus SolutionsTM Read more
Ziextenzo (pegfilgrastim-bmez Neulasta® Sandoz One Source Read more
Nyvepria (pegfilgrastim-apgf) Neulasta® Pfizer Oncology TogetherTM Read more
Stimufend (pegfilgrastim-fpgk) Neulasta® KabiCare Read more
Nivestym (filgrastim-aafi) Neupogen® Pfizer Oncology TogetherTM Read more
Releuko (filgrastim-ayow) Neupogen® Amneal PATHways® Read more
Zarxio (filgrastim-sndz) Neupogen® Sandoz One Source Read more
Avsola (infliximab-axxq) Remicade® Amgen Assist® Read more
Inflectra (infliximab-dyyb) Remicade® Pfizer enCompass® Read more
Renflexis(infliximab-abda) Remicade® Organon Access Program Read more
Riabni (rituximab-arrx) Rituxan® Amgen Assist 360® Read more
Ruxience (rituximab-pvvr) Rituxan® Pfizer Oncology TogetherTM Read more
Truxima (rituximab-abbs) Rituxan® Teva Shared Solutions® Read more

*Biosimilars Pipeline Report

Updated: 10/06/23

Connect with an expert

Find out more about how we can support your product or practice as the biosimilars market in the U.S. expands.